| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |